Opioid agonists produce analgesia in mammals through the activation of , , or ␦ opioid receptors. Previous behavioral and binding studies from our laboratory using an amphibian model suggested that , , or ␦ opioid agonists may activate a single type of opioid receptor in the grass frog, Rana pipiens. In the present study, kinetic, saturation, and competitive binding profiles for three opioid radioligands,were determined using frog whole brain homogenates. Kinetic analyses and experimentally derived values from saturation experiments gave affinity constants (K D ) in the low nanomolar range. The density of opioid binding sites (B max ) was 224.4, 118.6, and 268.9 fmol/mg for , , and ␦ opioid radioligands, respectively. The affinity values did not significantly differ among the three opioid radioligands, but the radioligand bound to significantly fewer sites than did the or ␦ radioligands. K i values for unlabeled , , and ␦ competitors, including highly selective opioid antagonists, were consistent with each radioligand selectivity profile. The present data suggest that , , and ␦ opioid radioligands bind to distinct opioid receptors in amphibians that are surprisingly similar to those found in mammalian brain.Pharmacological studies show that opioids produce analgesia in mammals through the activation of one or more of three distinct types of opioid receptors. Evidence for the multiplicity of opioid receptors in mammals was first noted with behavioral studies (Martin et al., 1976), was further confirmed by radioligand binding studies (Lord et al., 1977;Gillan et al., 1980), and was verified through molecular cloning techniques identifying three types of opioid receptors, the , , and ␦ opioid receptors (Raynor et al., 1994).Although a triad of opioid receptors is known to mediate opioid analgesia in humans and other mammals, it is not known which type of opioid receptors mediate opioid antinociception in nonmammalian vertebrates. The antinociceptive effects of a number of opioid agonists were shown in an amphibian model using a behavioral assay, the acetic acid test (Pezalla, 1983;Stevens and Pezalla, 1983;Stevens, 1988). The antinociception produced by these agents was shown to be opioid receptor-mediated as it was significantly blocked by the general opioid antagonists, naloxone and naltrexone (Stevens and Pezalla, 1984;Stevens et al., 1994). Selective , , and ␦ opioid agonists cause dose-dependent, naltrexone-reversible antinociceptive effects following systemic or central administration (Stevens et al., 1994;Stevens, 1996;Stevens and Rothe, 1997). Compared with results in mammals, the relative antinociceptive potency of selective , , and ␦ opioids is highly correlated following systemic and intraspinal administration in rodents and frogs (Stevens et al., 1994;Stevens, 1996). Thus, the amphibian model serves as an adjunct model for the testing of opioid analgesics, with unique advantages and disadvantages (Stevens, 1992(Stevens, , 1995 (Newman et al., 2000a,b). The rank order of [ 3 H]naloxone displacem...